“ASSOCIATION BETWEEN HEPARIN DOSE AND 6-WEEKS MORTALITY IN PATIENTS WITH COVID-19”, Mediterr J Hematol Infect Dis, vol. 14, no. 1, p. e2022036, Apr. 2022, doi: 10.4084/MJHID.2022.036.